MedTrace Logo

Diagnosis of Cancer Using Breath Samples

NCT01234987 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2011-10-28

No results posted yet for this study

Summary

The purpose of this study is to collect breath samples from healthy and cancer sick patients. The breath, collected to special bags, will be transferred to laboratories in the Technion and analyzed using an electronic nose system developed in Hossam Haick's labs (Chemical Engineering, Technion). The hypothesis is that based on the analysis of the chemical bio-markers present in the exhaled breath, cancer states can be distinguished from healthy subjects or before and after treatment, allowing a technique for diagnosis of cancer and/or cancer treatment.

Conditions

Sponsors & Collaborators

  • Rambam Hospital

    collaborator UNKNOWN

  • Technion, Israel Institute of Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01234987 on ClinicalTrials.gov